Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis
Treatment options are lacking to prevent photoreceptor death and subsequent vision loss. Previously, we demonstrated that reprogramming metabolism via the pharmacologic activation of PKM2 is a novel photoreceptor neuroprotective strategy. However, the features of the tool compound used in those stud...
Saved in:
Main Authors: | Thomas J. Wubben (Author), Sraboni Chaudhury (Author), Brennan T. Watch (Author), Jeanne A. Stuckey (Author), Eric Weh (Author), Roshini Fernando (Author), Moloy Goswami (Author), Mercy Pawar (Author), Jason C. Rech (Author), Cagri G. Besirli (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HSPB4/CRYAA Protect Photoreceptors during Retinal Detachment in Part through FAIM2 Regulation
by: Cagri G. Besirli, et al.
Published: (2024) -
Effects of Pyruvate Kinase M2 (PKM2) Gene Deletion on Astrocyte-Specific Glycolysis and Global Cerebral Ischemia-Induced Neuronal Death
by: Beom-Seok Kang, et al.
Published: (2023) -
De Novo Class of Momordicoside with Potent and Selective Tumor Cell Growth Inhibitory Activity as Pyruvate Kinase Muscle Isozyme 2 and Anti-apoptotic Myeloid Leukemia 1 Inhibitors
by: Tope Abraham Ibisanmi, et al.
Published: (2022) -
Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity
by: Chen C, et al.
Published: (2014) -
Targeting pyruvate kinase M2 for the treatment of kidney disease
by: Dan-Qian Chen, et al.
Published: (2024)